202 related articles for article (PubMed ID: 32462848)
1. [Not Available].
Balavoine JF
Rev Med Suisse; 2020 May; 16(695):1126. PubMed ID: 32462848
[No Abstract] [Full Text] [Related]
2. Treating COVID-19 with colchicine in community healthcare setting.
Della-Torre E; Della-Torre F; Kusanovic M; Scotti R; Ramirez GA; Dagna L; Tresoldi M
Clin Immunol; 2020 Aug; 217():108490. PubMed ID: 32492478
[No Abstract] [Full Text] [Related]
3. Surviving COVID-19: A disease tolerance perspective.
Ayres JS
Sci Adv; 2020 May; 6(18):eabc1518. PubMed ID: 32494691
[No Abstract] [Full Text] [Related]
4. SARS-CoV-2 positivity in a discharged COVID-19 patient: a case report.
Li J; Long X; Fang X; Zhang Q; Hu S; Lin Z; Xiong N
Clin Microbiol Infect; 2020 Aug; 26(8):1115-1117. PubMed ID: 32360448
[No Abstract] [Full Text] [Related]
5. COVID-19 with Pulmonary Involvement. An Autoimmune Disease of Known Cause.
Fernandez-Gutierrez B
Reumatol Clin (Engl Ed); 2020; 16(4):253-254. PubMed ID: 32345483
[No Abstract] [Full Text] [Related]
6. HIV and SARS-CoV-2: points to consider to face this new pandemic.
Prieto Pozo AA; Salvador Sagüez FLD
Medwave; 2020 Oct; 20(9):e8049. PubMed ID: 33141814
[TBL] [Abstract][Full Text] [Related]
7. [Not Available].
Fumeaux T
Rev Med Suisse; 2020 Nov; 16(714):2190. PubMed ID: 33174705
[No Abstract] [Full Text] [Related]
8. [Not Available].
Meylan P
Rev Med Suisse; 2020 Nov; 16(714):2190-2191. PubMed ID: 33174706
[No Abstract] [Full Text] [Related]
9. Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors.
Wu Q; Chu Q; Zhang H; Yang B; He X; Zhong Y; Yuan X; Chua MLK; Xie C
Cancer Commun (Lond); 2020 Aug; 40(8):374-379. PubMed ID: 32666636
[No Abstract] [Full Text] [Related]
10. [Not Available].
Nau JY
Rev Med Suisse; 2020 Jun; 16(696):1174-1175. PubMed ID: 32496708
[No Abstract] [Full Text] [Related]
11. The 2019 human coronavirus: Ten areas of uncertainty waiting to be resolved.
Mortimer PP
Rev Med Virol; 2020 Jul; 30(4):e2114. PubMed ID: 32394505
[No Abstract] [Full Text] [Related]
12. COVID-19 and Hypercoagulability.
Sholzberg M
Clin Adv Hematol Oncol; 2020 Jul; 18(7):386-389. PubMed ID: 32903249
[No Abstract] [Full Text] [Related]
13. COVID-19 serologic testing: FAQs and caveats.
Kadkhoda K
Cleve Clin J Med; 2020 Jun; 87(6):329-333. PubMed ID: 32434807
[No Abstract] [Full Text] [Related]
14. The type I interferon response in COVID-19: implications for treatment.
Lee JS; Shin EC
Nat Rev Immunol; 2020 Oct; 20(10):585-586. PubMed ID: 32788708
[TBL] [Abstract][Full Text] [Related]
15. Statin therapy and SAR-COV-2: an available and potential therapy?
Abdel-Latif RG; Mohammed S; Elgendy IY
Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):333-334. PubMed ID: 32379307
[No Abstract] [Full Text] [Related]
16. Immune monitoring of interleukin-7 compassionate use in a critically ill COVID-19 patient.
Monneret G; de Marignan D; Coudereau R; Bernet C; Ader F; Frobert E; Gossez M; Viel S; Venet F; Wallet F
Cell Mol Immunol; 2020 Sep; 17(9):1001-1003. PubMed ID: 32728202
[No Abstract] [Full Text] [Related]
17. COVID-19 management in light of the circadian clock.
Ray S; Reddy AB
Nat Rev Mol Cell Biol; 2020 Sep; 21(9):494-495. PubMed ID: 32699357
[TBL] [Abstract][Full Text] [Related]
18. Modeling infectious disease dynamics.
Cobey S
Science; 2020 May; 368(6492):713-714. PubMed ID: 32332062
[No Abstract] [Full Text] [Related]
19. [Not Available].
Meylan P
Rev Med Suisse; 2020 Jul; 16(700):1394. PubMed ID: 32672025
[No Abstract] [Full Text] [Related]
20. Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer Treatment.
Abid MB; Mughal M; Abid MA
JAMA Oncol; 2020 Oct; 6(10):1529-1530. PubMed ID: 32433719
[No Abstract] [Full Text] [Related]
[Next] [New Search]
